Description of event:
4th International Congress on
Biomarkers &
Clinical Research, during July 16-17, 2013 at Double Tree by Hilton Philadelphia Center City, USA, that can demonstrate the evidence from research and
clinical application in
Biomarker discovery and its potential application in
clinical practice. Special interest and theme of this conference is “Impact of
Biomarkers Development in Health
Diagnostics and
Clinical Research”.
The previous three conferences on
Biomarkers which were held at Santa Clara, USA (2010), Baltimore, USA (2011) and Embassy Suites Las Vegas, USA (2012) have explained Strategies and Developments in
Biomarkers and its
disease identification strategies have gained so much of interest for eminent scientists all over the world in
Pharmaceutical R&D.
Biomarkers-2013 focuses on the development and application of
biomarkers as key role indicators in health
diagnostics, has become a central strategy in a general re-evaluation of
drug discovery processes and points the way to major changes in health
diagnostics and
clinical research. This two day conference, assembles leading scientists, researchers, decision-makers and other players across the industry spectrum, that provides a unique opportunity to gain the latest
biomarker developments and its application in health
diagnostics,
oncology and in
clinical research.
Now it is the time to attend 4th International Congress on
Biomarkers &
Clinical Research to share about the
Biomarkers and its contributions of development in health
diagnostics and
clinical research which will be held in Double Tree by Hilton Philadelphia Center City, USA.
Conference Highlights the following topics:
Types of
Biomarkers and Approaches
Biomarkers:
Data Analysis
Biomarkers in
Clinical Research and Development
Biomarkers: Molecular Approaches
Omics Technologies in
Biomarkers Discovery and
Validation
Biomarkers of Exposure, Response, and Susceptibility
Enabling Technologies to Maximize
Biomarker Identification
Biomarkers: Disorders
Biomarkers in Microbial Infections
Biomarkers and
Nanoparticles
Current Research Concepts in
Biomarkers
4th International Congress on
Biomarkers &
Clinical Research, having the theme "Impact of
Biomarker Developments in Health
diagnostics and
Clinical Research."
Biomarkers-2013 is comprised of 11 tracks and 52 sessions designed to offer comprehensive sessions that address
current issues in 4th International Congress on
Biomarkers &
Clinical Research.
Types of
Biomarkers and Approaches
Track 1-1
Protein biomarkers
Track 1-2
Fluorescent biomarkers:
Antibody based and conjugated with
nanoparticles
Track 1-3
Blood biomarkers:
Serum and
blood cells
Track 1-4
Cancer biomarkers
Track 1-5
Biomarkers related to
DNA methylation and bones
Track 2:
Biomarkers:
Data Analysis
Track 2-1 Molecular profiling technologies
Track 2-2 Patient segmentation and stratification: Successful integration of
diagnostic tools
Track 2-3
Clinical data annotation: Classification distribution metrics, pattern recognition
Track 2-4 Perspectives on integrated approach to
biomarkers
Track 2-5 Statistics in
clinical studies
Track 3:
Biomarkers in
Clinical Research and Development
Track 3-1 Case study and
data management
Track 3-2
Clinical and non
clinical biomarkers
Track 3-3 Medical devices
Track 3-4 Pharmacovigilance
Track 3-5 Reproductive technologies
Track 3-6
Bioethics and intellectual property rights
Track 4:
Biomarkers: Molecular Approaches
Track 4-1
Transcription profiling and transcriptome
analysis
Track 4-2
Microarray technologies
Track 4-3 Epidemiological studies
Track 4-4
Biomarkers in karyotyping
Track 5: Omics Technologies in
Biomarkers Discovery and
Validation
Track 5-1
Data mining methods
Track 5-2
Genomic and proteomic approaches
Track 5-3 Metabolomics and metabonomics
Track 5-4
Biomarker discovery: Computational
biology
Track 5-5
Biomarkers and system
biology
Track 6:
Biomarkers of Exposure, Response, and Susceptibility
Track 6-1 Detection and measurement of endogenous substances
Track 6-2 Internal exposure and
genetic susceptibility to
drugs and
chemicals
Track 6-3 Toxodynamic parameters in pathological and biochemical changes
Track 6-4 Pharmacodynamic parameters in pathological and biochemical changes
Contact us:
Biomarkers-2013, OMICS Group Conferences
5716 Corsa Ave, Suite 110, Westlake, Los Angeles, CA 91362-7354, USA